A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ It’s been a turbulent stretch for 23andMe, the consumer DNA testing company once famous for its saliva-based ancestry kits. After grappling with financial losses, data breaches, lawsuits and a Chapter 11 bankruptcy filing, the company—and […]
Sam Altman-Backed Startup Aims to Add 10 Years to Human Life Through Stem Cell Tech
OpenAI’s Sam Altman has poured millions into the longevity-focused Retro Biosciences. Sean Gallup/Getty Images The average American can expect to live about 77 years, according to the Centers for Disease Control and Prevention. Retro Biosciences, a longevity startup backed by OpenAI CEO Sam Altman, aims to raise that number to 87 through cutting-edge medical research. […]